Akums Drugs, 3i Infotech and JD Cables to see some action today

Akums Drugs and Pharmaceuticals’ wholly-owned subsidiary -- Pure and Cure Healthcare has received approval from board for acquisition of Oriflame India’s manufacturing business for total consideration of Rs 56 crore. It includes two manufacturing plants at Roorkee, Uttarakhand and Noida, Uttar Pradesh, along with a leased warehouse situated at Noida. The object is to acquire the manufacturing business of Oriflame India situated at two locations i.e. Roorkee, Uttarakhand and Noida, Uttar Pradesh, along with a leased warehouse situated at Noida. This will expand Akums’ manufacturing capacity as well as capability of cosmetic and wellness products for Indian as well as global markets. 

3i Infotech has received Purchase Order from a leading domestic two-wheeler manufacturer for renewal of DMS Helpdesk Services. This is a one-year renewal, received in multiple Purchase Orders totaling Rs 6.32 crore, exclusive of applicable taxes.

JD Cables has been awarded with a significant work order from reputed Government and Private Entity for Manufacturing, Testing, Supply & Delivery of Cables & Conductors for around Rs 18 crore including GST. The said order is expected to be completed by September 2026.

PDS has transferred 409 equity shares, representing 2% of the share capital of DBS Lifestyle India (DBS Lifestyle). Consequent to the aforesaid transfer, the company's shareholding in DBS Lifestyle has reduced to around 49% of its equity share capital. Accordingly, DBS Lifestyle has ceased to be a subsidiary of the Company with effect from July 23, 2026, and shall henceforth continue as an associate of the Company. Consequent to the cessation of control over DBS Lifestyle, Suri Overseas and Pangram Brands Global, being indirect step-down subsidiaries of the Company through DBS Lifestyle, have also ceased to be step-down subsidiaries of the Company.

ACME Solar Holdings (ACME Solar), through its various subsidiaries, has, cumulatively, commissioned around 2.29 GWh Battery Energy Storage System (BESS) in the current financial year till date. With this milestone, the overall operational BESS capacity stands at around 3.62 GWh across 3 project sites in Rajasthan. This is one of the fastest scale-up of BESS capacity in India and represents a major step forward in strengthening grid stability, supporting peak-hour demand, and advancing the transition to reliable, round-the-clock renewable power

Coforge has launched Coforge Nuuron, an AI Operating System (AI-OS) designed to help enterprises move beyond isolated AI initiatives and industrialize AI-driven outcomes across the business. Built on years of investment in AI-native platforms including Coforge Forge-X, Coforge evolveOps.AI , Coforge CodeInsight.AI, Coforge Data Cosmos, Coforge Quasar, and BLUESWAN - this AIOS creates a unified operational layer that connects enterprise knowledge, workflows, decisions, and actions. It enables organizations to deploy agentic AI at scale while maintaining the governance, transparency, and control required for enterprise adoption.

Aurobindo Pharma’s wholly owned subsidiary -- Apitoria Pharma has received approval for the acquisition of 80% ownership in the Contract Research Services business of A1 Biochem Group, at an enterprise value of $17 million, on a debt-free and cash-free basis. Upon completion of the acquisition, Apitoria will hold 80% ownership in A1 Biochem Labs (India), India, with the existing promoter of A1 Biochem Group retaining the remaining 20% ownership. A1 Biochem Labs (India), India will acquire 100% ownership of A1 Biochem Labs LLC, USA and A1 Biochem Labs (India), India will acquire the business of A1 Biochem Research (India), India.